Stock Events

Stock Events

Invitae 

$0.02
359
-$0.01-35.59% Wednesday 20:59

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
4.62M
P/E Ratio
-0.16
Dividend Yield
-
Dividend
-

Earnings

26FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.76
-0.54
-0.32
-0.1
Expected EPS
-0.26
Actual EPS
N/A

Financials

-601.64%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
516.3MRevenue
-3.11BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVTA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing with Invitae's genetic testing services.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences offers cancer screening and diagnostic tests, competing in the genetic testing market alongside Invitae.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health specializes in liquid biopsies and cancer diagnostics, overlapping with Invitae's offerings in genetic health screenings and diagnostics.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics focuses on molecular diagnostic tests, including for cancer and mental health, directly competing with Invitae's genetic testing services.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that could compete with traditional genetic testing services by offering potential cures.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine works on gene editing using CRISPR, presenting a future competitive edge in genetic treatments against Invitae's diagnostic services.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is focused on developing gene-based medicines, which could rival Invitae's genetic testing by offering direct therapeutic solutions.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies, competing with Invitae in the genetic testing market by providing alternative or complementary technologies.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics provides genomic analysis tools, competing with Invitae in the structural variant detection and genetic analysis market.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of services and products for genetic analysis, including sequencing, making it a competitor in the broader genetic testing and analysis market.

About

Health Services
Medical/Nursing Services
Health Care and Social Assistance
Medical Laboratories
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Show more...
CEO
Employees
3000
Country
US
ISIN
US46185L1035
WKN
000A14NKG

Listings

0 Comments

Share your thoughts

FAQ

What is Invitae stock price today?▼
The current price of NVTA is $0.02 USD — it has decreased by -35.59% in the past 24 hours. Watch Invitae stock price performance more closely on the chart.
What is Invitae stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Invitae stocks are traded under the ticker NVTA.
What is Invitae market cap?▼
Today Invitae has the market capitalization of 4.62M
What is Invitae revenue for the last year?▼
Invitae revenue for the last year amounts to 516.3M USD.
What is Invitae net income for the last year?▼
NVTA net income for the last year is -3.11B USD.
How many employees does Invitae have?▼
As of April 05, 2026, the company has 3,000 employees.
In which sector is Invitae located?▼
Invitae operates in the Healthcare sector.
When did Invitae complete a stock split?▼
Invitae has not had any recent stock splits.
Where is Invitae headquartered?▼
Invitae is headquartered in San Francisco, US.